Awarded Excellence Prize at the 2024 Startup Campus Kick-Off
- 2024.04.15
DNC Biotechnology, the developer of the next-generation urine diagnostic solution Urine Check-IT, announced that its CEO, Park Sung-soo, has been recognized as an outstanding early-stage entrepreneur at Hannam University’s Startup-Centered University program. He was awarded the prestigious ‘Korea Startup Promotion Agency Director’s Award.’
Under the slogan “Paradigm Changer in Urine Diagnostics,” DNC Biotechnology has developed an innovative urine diagnostic solution addressing the challenges of traditional methods, such as contamination, infection risks, and unnecessarily complex testing processes. The company aims to improve medical professionals’ work environments, enhance the quality of healthcare services, and alleviate workforce shortages in medical settings.
Park Sung-soo, CEO of DNC Biotechnology, expressed his gratitude, stating, “I am honored to be recognized as an outstanding startup. We will continue to grow with humility and strive to become a global healthcare company that realizes sustainable growth and social value.”
© 2025 D&C Biotechnology Inc. All Rights Reserved.